Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.

  • J Schoemaker
  • L Stet
  • P Vrijland
  • Dieter Naber
  • J Panagides
  • R Emsley

Abstract

Safety and efficacy results, collected in schizophrenia and schizoaffective disorder patients treated for up to nearly 3 years, are presented for asenapine and olanzapine.

Bibliographical data

Original languageEnglish
Article number5
ISSN0176-3679
Publication statusPublished - 2012
pubmed 22454251